Atlas Trials

Resectable Gastric or Gastroesophageal Junction Adenocarcinoma

3 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Resectable Gastric or Gastroesophageal Junction Adenocarcinoma

RecordFirmDate
Evaluation, in Humans, of the Correlation Between Hepatotoxicity, Neurotoxicity Induced by Oxaliplatin, and Blood Levels of HMGB1 (NCT06649474)University Hospital, Clermont-Ferrand2024-09-06
Cadonilimab Combination With Chemotherapy With or Without AK117 in Resectable Gastric or Gastroesophageal Junction Adenocarcinoma (NCT05960955)Akeso2023-11-13
Trial of Neoadjuvant Durvalumab Plus Docetaxel, Oxaliplatin, S-1 Followed by Surgery and Adjuvant Durvalumab Plus S-1 Chemotherapy in Potentially Resectable MMR Proficient Gastric or Gastroesophageal Junction Adenocarcinoma (NCT04221555)Asan Medical Center2020-05-13

Track Resectable Gastric or Gastroesophageal Junction Adenocarcinoma automatically

Every clearance here is in the API, with alerts when new ones post.